SCHEMBL2858701

SCHEMBL2858701

CC1=NN(c2ccc(Cl)cc2S(=O)(=O)[O-])C(=O)C1N=Nc1ccc(OS(=O)(=O)c2ccc(C)cc2)cc1.[Na+]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 1/20 0.39
▸ ATIC P31939 1/20 0.50
▸ MEN1 O00255 12/20 0.46
▸ KMT2A Q03164 12/20 0.46
▸ MAPT P10636 6/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ ATM Q13315 1/20 0.45
▸ NPC1 O15118 6/20 0.41
▸ RAB9A P51151 6/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30371777 0.92 ATIC (0.60) ATICMEN1KMT2AMAPTCYP1A2
SCHEMBL2871328 0.79 SMN1; SMN2 (0.49) ATICMEN1KMT2AMAPTCYP1A2
SCHEMBL491025 0.75 ATIC (0.56) ATICMEN1KMT2AMAPTGAA
SCHEMBL18834108 0.75 ATIC (0.56) ATICMEN1KMT2AMAPTGAA
SCHEMBL3953142 0.74 MEN1 (0.51) MEN1KMT2AMAPTCYP1A2GAA
SCHEMBL226987 0.74 MEN1 (0.51) MEN1KMT2AMAPTCYP1A2GAA
SCHEMBL1615063 0.73 MEN1 (0.53) MEN1KMT2AMAPTCYP1A2GAA
SCHEMBL29960122 0.73 MEN1 (0.53) MEN1KMT2AMAPTCYP1A2GAA
SCHEMBL5940611 0.72 MEN1 (0.53) MEN1KMT2AMAPTCYP1A2GAA
SCHEMBL3953150 0.72 KMT2A (0.48) MEN1KMT2AMAPTCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017953-B1 DETERGENT SOLID COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2023-04-12 — — EP claimed
US-20220403193-A1 AQUEOUS INK COMPOSITION, INK SET, PRINTED MATERIAL, AND METHOD OF PRODUCING PRINTED MATERIAL DIC CORPORATION (JP) 2022-12-22 — — US claimed
EP-4067085-A1 AQUEOUS INK COMPOSITION, INKSET, PRINTED MATTER, AND METHOD FOR MANUFACTURING PRINTED MATTER DIC Corporation (JP) 2022-10-05 — — EP claimed
EP-4017953-A1 DETERGENT SOLID COMPOSITION Unilever IP Holdings B.V. (NL) 2022-06-29 — — EP claimed
CN-114641543-A Aqueous ink composition, ink set, printed matter, and method for producing printed matter DIC株式会社 2022-06-17 — — CN claimed
CN-114341325-A Solid detergent composition 联合利华知识产权控股有限公司 2022-04-12 — — CN claimed
US-20260062193-A1 DETERGENT PRODUCT CONOPCO, INC., D/B/A UNILEVER (US) 2026-03-05 — — US disclosed
EP-4532671-B1 LAUNDRY DETERGENT PRODUCT UNILEVER IP HOLDINGS B V (NL) 2026-02-11 — — EP disclosed
EP-4532667-B1 LAUNDRY DETERGENT PRODUCT UNILEVER IP HOLDINGS B V (NL) 2026-02-04 — — EP disclosed
EP-4608958-A1 COMPOSITION Unilever IP Holdings B.V. (NL) 2025-09-03 — — EP disclosed
EP-4581116-A1 DETERGENT PRODUCT Unilever IP Holdings B.V. (NL) 2025-07-09 — — EP disclosed
EP-4581118-A1 DETERGENT PRODUCT Unilever IP Holdings B.V. (NL) 2025-07-09 — — EP disclosed
EP-4581117-A1 DETERGENT PRODUCT Unilever IP Holdings B.V. (NL) 2025-07-09 — — EP disclosed
US-7713472-B2 Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-05-11 — — US disclosed
US-7651661-B2 Medical devices with broad spectrum antimicrobial activity BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-01-26 — — US disclosed
US-20080183152-A1 MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY RAAD ISSAM 2008-07-31 — — US disclosed
US-20070154621-A1 METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2007-07-05 — — US disclosed
US-20050197634-A1 Methods for coating and impregnating medical devices with antiseptic compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2005-09-08 — — US disclosed
US-5652093-A Analogues of reporter groups as background reducers in binding assays APROGENEX, INC. (US) 1997-07-29 — — US disclosed
US-5501952-A Analogues of reporter groups as background reducers in hybridization assays APROGENEX, INC. (US) 1996-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062193-A1 DETERGENT PRODUCT EXOSC10, LIPA, DERL1 THRB 4817/4885ATIC 2948/4885MEN1 4508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback